Banner

Surface Monitoring Recommendations for Hazardous Drugs: Does Health System Size or Location Matter?

Virtual Midday Symposium at the 2021 ASHP Midyear Clinical Meeting & Exhibition (Midyear registration not required)

Thursday, December 9, 2021
1:00 – 2:30 p.m. ET

Register Now

Available at least 24 hours before webinar.

Surface contamination with hazardous drugs (HDs) is an ongoing concern that has been addressed by organizations in the form of published standards and best practice guidelines, some of which are under revision and are not currently enforceable. In this activity, the faculty reviews the status of these documents, as well as applicable recommendations from international guidelines. The action plan for routine monitoring of surfaces for HD contamination and post-spill analysis implemented by one health system for use in its affiliated cancer institutes located in urban and rural communities is also described.

Learning Objectives

  • Summarize the status of USP Chapter <800> and other guidelines and consensus recommendations pertaining to the safe handling and monitoring of hazardous drugs (HDs) in the drug-use process. 
  • Apply strategies for implementing safe handling recommendations and HD monitoring.
  • List surfaces that should be monitored for HD contamination.
  • Develop an action plan for routine monitoring of surfaces for HD contamination and post-spill analysis based on the surface monitoring results.

Agenda

1:00 p.m. 
Welcome and Introduction
Patricia C. Kienle, M.P.A., BCSCP, FASHP

1:05 p.m.
Where Are We Now? Reflections on Domestic and International Guidelines for Monitoring Hazardous Drug Contamination 
Patricia C. Kienle, M.P.A., BCSCP, FASHP

1:35 p.m. 
Telling Our Story: Practical Approaches to Monitoring Surfaces for Hazardous Drug Contamination 
Andre D. Harvin, Pharm.D., M.S., and Clinton L. Meachum, CPhT, CSPT

2:10 p.m.
Faculty Discussion and Q&A: Breaking Down Barriers to Put Strategies into Practice 
All faculty

Faculty

Patricia C. Kienle, M.P.A., BCSCP, FASHP, Activity Chair
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

Andre D. Harvin, Pharm.D., M.S.
Director of Pharmacy, Oncology
Cone Health
Greensboro, North Carolina

Clinton L. Meachum, CPhT, CSPT
Compounding Regulatory Coordinator
Cone Health
Greensboro, North Carolina

Target Audience

This activity was planned to meet the educational needs of pharmacists and pharmacy technicians involved with handling hazardous drugs in clinics, infusion centers, hospitals, and health systems of any size.

Format 
This activity features slide presentations, active learning, and questions/discussion with faculty. 

CPE Information

ACPE #: 0204-0000-21-433-L07-P/T
Activity Type: Application-based
CE Credits: 1.5 contact hours (0.15 CEUs)
Activity Fee: Free of charge

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity is accredited for both pharmacists and pharmacy technicians and qualifies for compounding CPE!

 

 

Claim CE by February 1, 2022

Claim CE (enter the CE code announced during activity and complete the evaluation).

Verify credit has posted to your ​NABP eProfile account before the February 1, 2022 deadline.

After the ACPE deadline, ASHP will no longer be able to report credits.

Join the Live Broadcast

Join the live interactive webinar using your computer or smart device. 

Watch for a confirmation email with additional instructions. 

Get the app and view system requirements